A
Anna Lübking
Researcher at Lund University
Publications - 22
Citations - 550
Anna Lübking is an academic researcher from Lund University. The author has contributed to research in topics: Discontinuation & Myeloid leukemia. The author has an hindex of 11, co-authored 20 publications receiving 433 citations.
Papers
More filters
Journal ArticleDOI
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.
Mette Ilander,Ulla Olsson-Strömberg,Ulla Olsson-Strömberg,Heinrich Schlums,Joelle Guilhot,Oscar Brück,Hanna Lähteenmäki,Tiina Kasanen,Perttu Koskenvesa,Stina Söderlund,Martin Höglund,Berit Markevärn,Anders Själander,Kourosh Lotfi,Arta Dreimane,Anna Lübking,Elis Holm,Mats Björeman,Sören Lehmann,Sören Lehmann,Sören Lehmann,Leif Stenke,Lotta Ohm,Tobias Gedde-Dahl,Waleed Majeed,Hans Ehrencrona,S Koskela,Susanne Saussele,Mahon Fx,Kimmo Porkka,Henrik Hjorth-Hansen,Yenan T. Bryceson,Johan Richter,Satu Mustjoki +33 more
TL;DR: The role of NK cells in sustaining remission is highlighted and the status of CML as an immunogenic tumor warranting novel clinical trials with immunomodulating agents is strengthened.
Journal ArticleDOI
Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Discontinuation of Imatinib: A Tyrosine Kinase Inhibitor Withdrawal Syndrome?
Johan Richter,Stina Söderlund,Anna Lübking,Arta Dreimane,Kourosh Lotfi,Berit Markevärn,Anders Själander,Susanne Saussele,Ulla Olsson-Strömberg,Leif Stenke +9 more
TL;DR: Musculoskeletal pain in patients with chronic myeloid leukemia after discontinuation of Imatinib : a Tyrosine Kinase Inhibitor withdrawal syndrome?
Journal ArticleDOI
FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesis.
Christina Jensen,Christina Jensen,Shabnam Kharazi,Charlotta Böiers,Min Cheng,Anna Lübking,Ewa Sitnicka,Sten Eirik W. Jacobsen,Sten Eirik W. Jacobsen +8 more
TL;DR: It is demonstrated that, rather than TSLP, IL-7 and FLT3 ligand are combined responsible for all B-cell generation in mice, including recently identified B-1-specified cell progenitors, which regulates alternative pathways of fetal and adult B- 1 and B-2 lymphopoiesis.
Journal ArticleDOI
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry.
Anna Lübking,Arta Dreimane,Fredrik Sandin,Cecilia Isaksson,Berit Markevärn,Mats Brune,Per Ljungman,Stig Lenhoff,Leif Stenke,Martin Höglund,Johan Richter,Ulla Olsson-Strömberg +11 more
TL;DR: It is indicated that allo-HSCT still constitutes a reasonable therapeutic option for patients with CML in first CP, especially those resistant to TKI treatment, providing high long-term survival and low non-relapse mortality.
Journal ArticleDOI
Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry.
Emma Bergfelt Lennmyr,Karin Karlsson,Lucia Ahlberg,Hege Garelius,Erik Hulegårdh,Antonio Santamaria Izarra,Joel Joelsson,Piotr Kozlowski,Andreea Moicean,Beata Tomaszewska-Toporska,Anna Lübking,Helene Hallböök +11 more
TL;DR: As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results of clinical trials need to relate to standard of care.